Quadrant Capital Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.5K | Sell |
19,417
-3,679
| -16% | -$14.6K | ﹤0.01% | 1590 |
|
|
2025
Q4 | $81.1K | Buy |
23,096
+7,056
| +44% | +$24.2K | ﹤0.01% | 1540 |
|
|
2025
Q3 | $52.3K | Buy |
+16,040
| New | +$50.5K | ﹤0.01% | 1660 |
|
|
2025
Q2 | – | Sell |
-26,825
| Closed | -$179K | – | 2304 |
|
|
2025
Q1 | $179K | Buy |
26,825
+25,590
| +2,072% | +$253K | 0.01% | 1350 |
|
|
2024
Q4 | $15.5K | Buy |
1,235
+1,076
| +677% | +$16.2K | ﹤0.01% | 1986 |
|
|
2024
Q3 | $2.94K | Buy |
159
+55
| +53% | +$1.13K | ﹤0.01% | 2431 |
|
|
2024
Q2 | $2.24K | Hold |
104
| – | – | ﹤0.01% | 2457 |
|
|
2024
Q1 | $2.8K | Hold |
104
| – | – | ﹤0.01% | 2440 |
|
|
2023
Q4 | $3.12K | Hold |
104
| – | – | ﹤0.01% | 2389 |
|
|
2023
Q3 | $2.13K | Hold |
104
| – | – | ﹤0.01% | 2373 |
|
|
2023
Q2 | $2.07K | Hold |
104
| – | – | ﹤0.01% | 2405 |
|
|
2023
Q1 | $1.78K | Hold |
104
| – | – | ﹤0.01% | 2447 |
|
|
2022
Q4 | $2.04K | Hold |
104
| – | – | ﹤0.01% | 2413 |
|
|
2022
Q3 | $2K | Hold |
104
| – | – | ﹤0.01% | 2413 |
|
|
2022
Q2 | $1K | Buy |
104
+92
| +767% | +$1.1K | ﹤0.01% | 2434 |
|
|
2022
Q1 | $0 | Sell |
12
-33
| -73% | -$570 | ﹤0.01% | 2663 |
|
|
2021
Q4 | $1K | Sell |
45
-16
| -26% | -$436 | ﹤0.01% | 2386 |
|
|
2021
Q3 | $2K | Sell |
61
-47
| -44% | -$1.71K | ﹤0.01% | 2184 |
|
|
2021
Q2 | $5K | Buy |
108
+63
| +140% | +$2.74K | ﹤0.01% | 1852 |
|
|
2021
Q1 | $2K | Hold |
45
| – | – | ﹤0.01% | 2109 |
|
|
2020
Q4 | $2K | Hold |
45
| – | – | ﹤0.01% | 1988 |
|
|
2020
Q3 | $1K | Buy |
+45
| New | +$1.11K | ﹤0.01% | 2038 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
